Day One Biopharmaceuticals, Inc. logo DAWN - Day One Biopharmaceuticals, Inc.

Inactive Ticker DAWN is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 6
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $21.50 DETAILS
HIGH: $21.50
LOW: $21.50
MEDIAN: $21.50
CONSENSUS: $21.50
DOWNSIDE: 0.14%
Metric 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 53.7 39.8 33.9 30.8 29.2 93.8 8.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 6.1 4.5 3.8 2.9 3.0 1.6 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 47.6 35.3 30.1 27.9 26.2 92.2 7.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 40.9 31.4 36.1 39.6 61.8 33.6 92.1 40.2 37.3 33.2 32.2 27.8 26.0 22.0 22.6 15.0 11.2 9.8 9.9 12.6 4.2 2.5 1.4 1.0
SG&A Expenses 34.1 28.1 29.0 29.3 29.7 29.0 30.2 26.6 22.2 18.3 17.1 18.0 16.7 17.7 14.2 12.7 10.8 9.4 5.5 3.5 2.0 1.0 0.9 0.8
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 75.1 59.6 65.1 68.9 91.6 62.5 122.3 66.8 59.5 51.4 49.3 45.9 42.7 39.7 36.7 27.7 22.0 19.2 15.4 16.1 6.1 3.6 2.3 1.8
Operating Income
Operating Income (27.5) (24.3) (35.0) (41.1) (65.3) 29.6 (114.8) (66.8) (59.5) (51.4) (49.3) (45.9) (42.7) (39.7) (36.7) (27.7) (22.0) (19.2) (15.4) (16.1) (6.1) (3.6) (2.3) (1.8)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Interest Income 4.1 4.6 4.7 5.1 6.1 5.3 4.0 4.4 5.0 5.3 3.4 3.5 2.7 1.9 0.2 0.0 0 0 0 0 0 0 0 0
Profitability
EBITDA (26.5) (23.3) (34.0) (40.2) (64.6) 30.4 (114.4) (66.7) (59.4) (51.3) (49.2) (45.8) (42.6) (39.5) (36.6) (27.7) (21.9) (19.2) (15.4) (16.0) (35.5) (3.8) (2.4) (2.0)
EBIT (27.5) (24.3) (35.0) (41.1) (65.3) 29.6 (114.8) (66.8) (59.5) (51.4) (49.3) (45.9) (42.7) (39.7) (36.7) (27.7) (21.9) (19.2) (15.4) (16.1) (35.6) (3.8) (2.4) (2.0)
Income Before Tax (23.3) (19.7) (30.3) (36.0) (59.2) 36.2 (2.9) (62.4) (54.5) (46.1) (45.9) (42.4) (40.1) (37.8) (36.5) (27.7) (21.9) (19.2) (15.5) (16.1) (35.6) (3.8) (2.4) (2.0)
Income Tax Expense (2.0) 0 0 0 6.5 (0.9) 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (21.3) (19.7) (30.3) (36.0) (65.7) 37.0 (4.4) (62.4) (54.5) (46.1) (45.9) (42.4) (40.1) (37.8) (36.5) (27.7) (21.9) (19.2) (14.3) (15.2) (34.4) (2.8) (1.8) (1.5)
Per Share Data
EPS (Basic) -0.21 -0.19 -0.29 -0.35 -0.70 0.38 -0.05 -0.72 -0.62 -0.54 -0.61 -0.49 -0.47 -0.48 -0.60 -0.48 -1.93 -0.31 -0.23 -0.25 -0.56 -0.05 -0.03 -0.02
EPS (Diluted) -0.21 -0.19 -0.29 -0.35 -0.70 0.38 -0.05 -0.72 -0.62 -0.54 -0.61 -0.49 -0.47 -0.48 -0.60 -0.48 -1.93 -0.31 -0.23 -0.25 -0.56 -0.05 -0.03 -0.02
Shares Outstanding 103.4 103.4 103.1 102.7 93.6 96.6 87.1 86.7 87.2 86.0 75.0 72.0 73.5 71.0 60.8 58.4 62.0 61.9 61.9 61.9 61.9 61.9 61.9 61.9
Metric 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 197.1 43.3 35.6 33.4 125.0 422.8 239.6 270.4 230.8 241.2 189.2 49.3 85.3 120.9 388.9 262.7 284.3 297.2 310.0 154.9 43.7
Short-Term Investments 244.0 408.3 417.5 439.7 406.8 135.6 122.2 47.6 135.6 164.4 253.7 268.9 257.0 253.5 6.0 0 0 0 0 0 0
Net Receivables 26.7 16.7 19.7 18.1 13.9 8.7 9.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 6.3 7.1 6.5 3.6 3.3 2.7 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 10.9 3.5 3.8 4.0 4.4 3.4 7.6 4.6 2.4 2.2 0.8 0.8 1.0 0.9 0.8 0.4 1.0 0.2 0.2 0.1 1.3
Total Current Assets 485.1 490.0 494.4 508.7 562.3 581.0 383.2 326.0 375.3 413.3 449.8 322.4 347.9 380.5 402.5 267.4 289.4 303.3 316.0 158.8 45.1
Non-Current Assets
Property, Plant & Equipment 4.5 4.7 4.8 5.1 4.7 3.5 0.4 0.4 0.6 0.7 0.7 0.7 0.7 0.9 1.1 0.2 0.3 0.3 0.4 0.4 0.5
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 18.0 18.8 19.6 20.4 15.6 16.2 16.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.5 0.5 0.4 0.5 0.2 0.2 0.1 0.1 1.7 0.1
Total Non-Current Assets 22.7 23.8 24.6 25.7 20.5 19.8 17.3 0.6 0.8 0.9 1.0 1.2 1.2 1.3 1.5 0.4 0.5 0.5 0.5 2.1 0.6
Total Assets 507.8 513.8 519.0 534.4 582.8 600.8 400.4 326.6 376.0 414.2 450.8 323.6 349.1 381.9 404.0 267.8 289.8 303.8 316.5 160.9 45.7
Current Liabilities
Account Payables 3.7 5.8 5.1 2.5 3.3 3.0 6.4 4.8 2.6 3.4 4.6 4.7 0.3 4.0 0.4 0.7 1.7 0.7 0.3 0.7 0.2
Short-Term Debt 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0
Deferred Revenue 2 2.3 1.8 1.6 1.6 1.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 54.6 39.2 37.5 39.4 54.7 23.7 80.5 20.7 17.4 13.6 14.4 15.0 9.8 8.8 9.1 5.7 0.1 0.2 0.7 0.7 0.0
Total Current Liabilities 60.5 56.5 51.2 47.9 73.5 39.7 93.7 29.8 29.5 24.5 24.5 22.8 16.6 18.3 12.8 8.2 8.7 6.0 4.7 3.1 2.0
Non-Current Liabilities
Long-Term Debt 2.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 3.5 0.8 0.8 0.8 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 92.0
Total Non-Current Liabilities 6.1 6.4 7.0 7.0 6.6 5.6 0 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0 0.0 0.1 0.1 0.2 92.2
Total Liabilities 66.7 62.9 58.2 54.8 80.0 45.3 93.7 29.8 29.5 24.6 24.7 23.1 17.0 18.8 13.4 8.2 8.7 6.1 4.8 3.2 94.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 2
Retained Earnings (661.4) (640.1) (620.4) (590.1) (554.1) (488.4) (525.4) (521.0) (458.6) (404.1) (357.9) (312.1) (269.7) (229.6) (191.8) (155.2) (127.5) (105.5) (86.3) (72.0) (56.8)
Accumulated Other Comprehensive Income 0.1 0.1 (0.1) (0.1) 0.1 (0.0) (0.0) (0.0) 0.0 (0.0) (0.0) 0.1 (0.1) (0.4) (0.0) 0 0 (303.8) 0 0 0.6
Total Stockholders' Equity 441.2 450.9 460.8 479.5 502.8 555.5 306.7 296.8 346.5 389.6 426.1 300.4 332.0 363.1 390.6 259.6 281.1 297.7 311.8 152.9 (54.2)
Total Liabilities & Equity 507.8 513.8 519.0 534.4 582.8 600.8 400.4 326.6 376.0 414.2 450.8 323.6 349.1 381.9 404.0 267.8 289.8 303.8 316.5 160.9 45.7
Debt Metrics
Total Debt 2.8 2.9 3.0 2.9 2.6 2.6 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1.0 1.0 0.2 0.2 0.3 0.3 0.4 0.4
Net Debt (194.3) (40.4) (32.6) (30.4) (122.4) (420.1) (239.4) (270.1) (230.4) (240.7) (188.6) (48.6) (84.4) (119.9) (387.8) (262.6) (284.1) (296.9) (309.7) (154.5) (43.3)
Metric 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (21.3) (19.7) (30.3) (36.0) (65.7) 37.0 (4.4) (62.4) (54.5) (46.1) (45.9) (42.4) (40.1) (37.8) (36.5) (27.7) (21.9) (19.2) (15.5) (16.1) (35.6) (3.8) (2.4) (2.0)
Depreciation & Amortization 0.9 0.9 0.9 0.8 0.8 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Stock-Based Compensation 11.1 9.6 10.9 12.9 11.0 11.6 13.0 12.6 10.8 9.6 9.5 9.4 6.8 8.6 5.6 6.2 5.1 5.1 2.5 0.5 0.3 0.1 0.1 0.1
Change in Working Capital (1.7) 7.5 (2.3) (32.5) 26.7 (52.2) 50.7 1.2 3.8 (1.0) (0.9) 7.5 (1.2) 6.9 1.0 (0.1) 3.6 1.8 (0.5) (2.2) (0.2) (0.1) 0.3 (0.4)
Other Non-Cash Items (3.1) (4.1) (4.0) (4.2) (2.8) 53.6 (108.9) (1.3) (43.2) 46.1 (9.5) (0.6) (1.0) (1.0) 0 0 (0.0) 0.0 0.0 8.0 30.0 0.0 0.0 0.0
Operating Cash Flow (14.1) (5.8) (24.8) (59.0) (30.0) 50.8 (49.1) (49.7) (41.4) (37.1) (42.4) (26.0) (35.3) (23.2) (29.8) (21.6) (13.2) (12.2) (13.4) (9.7) (5.9) (3.6) (1.9) (2.1)
Investing Activities
Capital Expenditure (3.5) 0 3.5 (3.8) (1.4) (55.7) (17.1) 0 (0.0) (3.0) (0.1) (0.0) 0 (0.0) (0.0) (0.0) 8 0 0 (8) 0.0 0 (0.0) (0.1)
Acquisitions 0 0 0 0 0 0 0 0 (3.0) 3 (0.0) 0.0 0 (20) 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (57.9) (209.6) (238.5) (189.8) (275.2) (214.6) (121.6) (47.2) (99.1) (80.0) (104.7) (160.0) (121.4) (266.8) (6.0) 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 225.4 223.0 264.8 161 7 202.7 47.8 136.4 129.5 171.9 125.2 148.8 119.2 20 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 (3.5) (17.1) (55) 108 0 3.0 (3) 0.0 (0.0) 0 20 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 167.5 13.5 26.3 (32.6) (269.6) (67.7) 17.1 89.3 30.4 88.9 20.3 (11.2) (2.2) (246.9) (6.0) (0.0) 8 0 0 (8) 0.0 0 (0.0) (0.1)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 21.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Financing Cash Flow 0.5 0 0.7 0 1.9 200.1 1.3 0.0 0.6 0.1 162.1 1.2 1.9 2.1 161.9 0 0.3 (0.6) 168.5 128.9 30.0 0 0 0
Cash Position
Net Change in Cash 153.8 7.7 2.3 (91.6) (297.8) 183.1 (30.8) 39.6 (10.4) 52.0 139.9 (36.0) (35.6) (268.0) 126.1 (21.6) (12.9) (12.8) 155.1 111.1 24.0 (3.6) (1.9) (2.2)
Cash at Beginning 43.3 35.6 33.4 125.0 422.8 239.6 270.4 230.8 241.2 189.2 49.3 85.3 120.9 388.9 262.7 284.3 297.2 310.0 154.9 43.7 19.7 23.3 25.2 27.3
Cash at End 197.1 43.3 35.6 33.4 125.0 422.8 239.6 270.4 230.8 241.2 189.2 49.3 85.3 120.9 388.9 262.7 284.3 297.2 310.0 154.9 43.7 19.7 23.3 25.2
Free Cash Flow (17.6) (5.8) (21.3) (62.8) (31.4) (5.0) (66.3) (49.7) (41.4) (40.1) (42.6) (26.0) (35.3) (23.2) (29.8) (21.6) (5.2) (12.2) (13.4) (17.7) (5.9) (3.6) (1.9) (2.2)
Key Metrics 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 53.7 39.8 33.9 30.8 29.2 93.8 8.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 47.6 35.3 30.1 27.9 26.2 92.2 7.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (27.5) (24.3) (35.0) (41.1) (65.3) 29.6 (114.8) (66.8) (59.5) (51.4) (49.3) (45.9) (42.7) (39.7) (36.7) (27.7) (22.0) (19.2) (15.4) (16.1) (6.1) (3.6) (2.3) (1.8)
Net Income (21.3) (19.7) (30.3) (36.0) (65.7) 37.0 (4.4) (62.4) (54.5) (46.1) (45.9) (42.4) (40.1) (37.8) (36.5) (27.7) (21.9) (19.2) (14.3) (15.2) (34.4) (2.8) (1.8) (1.5)
EPS (Diluted) -0.21 -0.19 -0.29 -0.35 -0.70 0.38 -0.05 -0.72 -0.62 -0.54 -0.61 -0.49 -0.47 -0.48 -0.60 -0.48 -1.93 -0.31 -0.23 -0.25 -0.56 -0.05 -0.03 -0.02
Balance Sheet
Cash & Equivalents 197.1 43.3 35.6 33.4 125.0 422.8 239.6 270.4 230.8 241.2 189.2 49.3 85.3 120.9 388.9 262.7 284.3 297.2 310.0 154.9 43.7
Total Assets 507.8 513.8 519.0 534.4 582.8 600.8 400.4 326.6 376.0 414.2 450.8 323.6 349.1 381.9 404.0 267.8 289.8 303.8 316.5 160.9 45.7
Total Debt 2.8 2.9 3.0 2.9 2.6 2.6 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1.0 1.0 0.2 0.2 0.3 0.3 0.4 0.4
Stockholders' Equity 441.2 450.9 460.8 479.5 502.8 555.5 306.7 296.8 346.5 389.6 426.1 300.4 332.0 363.1 390.6 259.6 281.1 297.7 311.8 152.9 (54.2)
Cash Flow
Operating Cash Flow (14.1) (5.8) (24.8) (59.0) (30.0) 50.8 (49.1) (49.7) (41.4) (37.1) (42.4) (26.0) (35.3) (23.2) (29.8) (21.6) (13.2) (12.2) (13.4) (9.7) (5.9) (3.6) (1.9) (2.1)
Capital Expenditure (3.5) 0 3.5 (3.8) (1.4) (55.7) (17.1) 0 (0.0) (3.0) (0.1) (0.0) 0 (0.0) (0.0) (0.0) 8 0 0 (8) 0.0 0 (0.0) (0.1)
Free Cash Flow (17.6) (5.8) (21.3) (62.8) (31.4) (5.0) (66.3) (49.7) (41.4) (40.1) (42.6) (26.0) (35.3) (23.2) (29.8) (21.6) (5.2) (12.2) (13.4) (17.7) (5.9) (3.6) (1.9) (2.2)